Delivery constructs for transcytosis and related methods
US11027020B2 · kind B2 · utility
7Cited by
17References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 15, 2020 |
| Grant date | Jun 8, 2021 |
| Priority date | — |
| Expiry date | Jun 15, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K1/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides non-naturally occurring fusion molecules comprising therapeutic cargo moieties, such as IL-22 with a carrier. The disclosure also provides methods and compositions for the production, purification, refolding, formulation, and administration of fusion molecules. Methods and for using the purified molecules to treat and prevent diseases or disorders are also provided herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.